LINC01982

Across TCGA pan-cancer cohorts, LINC01982 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC01982’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01982 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01982 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and BLCA are the cancer types where LINC01982 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01982 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	III,IV	−0.856	<.001	9	view →
LUSC	Female	All	−0.581	<.001	7	view →
BLCA	Female	IV	−0.200	<.001	7	view →
KIRC	All	II,III,IV	−0.058	.002	6	view →
COAD	All	All	−0.308	<.001	5	view →
BRCA	All	All	−0.042	.025	3	view →
UCEC	All	All	−0.270	.022	2	view →
PRAD	All	All	−0.174	.002	2	view →
THCA	All	All	−0.043	.032	2	view →
STAD	Female	III,IV	+0.480	.013	1	view →
KICH	All	II,III,IV	−0.131	.047	1	view →
KIRP	All	All	−0.071	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

LINC01982–LUAD

Open the LUAD breakdown →